共 214 条
Chitosan-based delivery systems for protein therapeutics and antigens
被引:478
作者:
Amidi, Maryam
[1
]
Mastrobattista, Enrico
[1
]
Jiskoot, Wim
[2
]
Hennink, Wim E.
[1
]
机构:
[1] Univ Utrecht, UIPS, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] Leiden Univ, LACDR, Div Drug Delivery Technol, NL-2300 RA Leiden, Netherlands
关键词:
Chitosan;
Trimethylated chitosan (TMC);
Protein/peptides delivery;
Mucosal delivery;
Targeting;
Vaccination;
Micro- and nanoparticles;
N-TRIMETHYL CHITOSAN;
IN-VITRO EVALUATION;
BORDETELLA-BRONCHISEPTICA ANTIGENS;
NASAL ABSORPTION ENHANCEMENT;
BRONCHIAL LYMPHOID-TISSUE;
PEPTIDE DRUG-DELIVERY;
T-CELL EPITOPES;
MOLECULAR-WEIGHT;
INTRANASAL IMMUNIZATION;
IMMUNE-RESPONSES;
D O I:
10.1016/j.addr.2009.11.009
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Therapeutic peptides/proteins and protein-based antigens are chemically and structurally labile compounds, which are almost exclusively administered by parenteral injections. Recently, non-invasive mucosal routes have attracted interest for administration of these biotherapeutics. Chitosan-based delivery systems enhance the absorption and/or cellular uptake of peptides/proteins across mucosal sites and have immunoadjuvant properties. Chitosan is a mucoadhesive polysaccharide capable of opening the tight junctions between epithelial cells and it has functional groups for chemical modifications, which has resulted in a large variety of chitosan derivatives with tunable properties for the aimed applications. This review provides an overview of chitosan-based polymers for preparation of both therapeutic peptides/protein and antigen formulations. The physicochemical properties of these carrier systems as well as their applications in protein and antigen delivery through parenteral and mucosal (particularly nasal and pulmonary) administrations are summarized and discussed. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 82
页数:24
相关论文